Regulators: Focus Global Harmonization Efforts on Rare Disease Trials
May 28, 2021
Regulatory officials from the U.S., UK, EU and Japan said their agencies should harmonize rules for clinical trials targeting rare diseases because patient populations in some study areas number only in the hundreds worldwide. If enacted, such a strategy could lead to faster development of advanced therapy medicinal products used to treat ultra-rare diseases.